CN Patent

CN101133082B — 酰化的glp-1化合物

Assigned to Novo Nordisk AS · Expires 2016-01-13 · 10y expired

What this patent protects

长效GLP-1化合物及其治疗用途。

USPTO Abstract

长效GLP-1化合物及其治疗用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101133082B
Jurisdiction
CN
Classification
—
Expires
2016-01-13
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.